• Published on 2024-08-21
    • Report Code: 2102
    • 170-350 pages

Metabolomics Market

Metabolomics Market Size, Share, and Analysis, By Product and Service (Metabolomics Instruments, Separation Tools, and Detection Tools),  By Application (Biomarker discovery, Drug Discovery, Personalized Medicine, Toxicology Testing, Nutrigenomics, Functional Genomics, Other Applications), By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Inborn Errors of Metabolism, Other), By End-User (Contract Research Organizations, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Other End-users) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034

Table Of Content

1.Executive Summary

1.1. Regional Market Share

1.2.Business Trends

1.3. Metabolomics Market: COVID-19 Outbreak

1.4. Regional Trends

1.5. Segmentation Snapshot

2. Research Methodology

2.1.Research Objective 

2.2. Research Approach 

2.3. Data Sourcing and Methodology

2.4.Primary Research

2.5.Secondary Research

2.5.1.Paid Sources

2.5.2. Public Sources 

2.6. Market Size Estimation and Data Triangulation 

3. Market Characteristics 

3.1.Market Definition

3.2.Metabolomics Market: COVID-19 Impact

3.3. Key Segmentations 

3.4.Key Developments

3.5.Allied Industry Data

4.Metabolomics Market – Industry Insights

4.1. Industry Segmentation

4.2.COVID-19 overview on world economy

4.3.Industry ecosystem Channel analysis

4.4.Innovation & Sustainability

5. Macroeconomic Indicators

6. Recent Developments

7. Market Dynamics

7.1.Introduction

7.2. Growth Drivers

7.3. Market Opportunities 

7.4.Market Restraints

7.5. Market Trends

8.Risk Analysis

9. Market Analysis

9.1.Porters Five Forces

9.2. PEST Analysis

9.2.1.Political

9.2.2. Economic

9.2.3. Social

9.2.4. Technological

10.Metabolomics Market

10.1.Overview

10.2. Historical Analysis (2019-2022)

10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast

11. Metabolomics Market Size & Forecast 2024A-2034F 

11.1. Overview 

11.2.Key Findings

11.3.Market Segmentation

11.3.1.By Product and Services

11.3.1.1. Metabolomics Instruments

11.3.1.1.1.By Value (USD Million) 2024-2034F

11.3.1.1.2. Market Share (%) 2024-2034F

11.3.1.1.3. Y-o-Y Growth (%) 2024-2034F

11.3.1.2.Separation Tools

11.3.1.2.1. By Value (USD Million) 2024-2034F

11.3.1.2.2.Market Share (%) 2024-2034F

11.3.1.2.3.Y-o-Y Growth (%) 2024-2034F

11.3.1.3.Detection Tools

11.3.1.3.1. By Value (USD Million) 2024-2034F

11.3.1.3.2.Market Share (%) 2024-2034F

11.3.1.3.3.Y-o-Y Growth (%) 2024-2034F

11.3.2. By Application

11.3.2.1.Biomarker Discovery

11.3.2.1.1. By Value (USD Million) 2024-2034F

11.3.2.1.2.Market Share (%) 2024-2034F

11.3.2.1.3.Y-o-Y Growth (%) 2024-2034F

11.3.2.2. Drug Discovery

11.3.2.2.1.By Value (USD Million) 2024-2034F

11.3.2.2.2. Market Share (%) 2024-2034F

11.3.2.2.3. Y-o-Y Growth (%) 2024-2034F

11.3.2.3. Personalized Medicine

11.3.2.3.1.By Value (USD Million) 2024-2034F

11.3.2.3.2. Market Share (%) 2024-2034F

11.3.2.3.3. Y-o-Y Growth (%) 2024-2034F

11.3.2.4. Toxicology Testing

11.3.2.4.1.By Value (USD Million) 2024-2034F

11.3.2.4.2. Market Share (%) 2024-2034F

11.3.2.4.3. Y-o-Y Growth (%) 2024-2034F

11.3.2.5. Nutrigenomics

11.3.2.5.1.By Value (USD Million) 2024-2034F

11.3.2.5.2. Market Share (%) 2024-2034F

11.3.2.5.3. Y-o-Y Growth (%) 2024-2034F

11.3.2.6. Functional Genomics

11.3.2.6.1.By Value (USD Million) 2024-2034F

11.3.2.6.2. Market Share (%) 2024-2034F

11.3.2.6.3. Y-o-Y Growth (%) 2024-2034F

11.3.2.7. Other Applications

11.3.2.7.1.By Value (USD Million) 2024-2034F

11.3.2.7.2. Market Share (%) 2024-2034F

11.3.2.7.3. Y-o-Y Growth (%) 2024-2034F

11.3.3.By Indication

11.3.3.1.Cancer

11.3.3.1.1. By Value (USD Million) 2024-2034F

11.3.3.1.2.Market Share (%) 2024-2034F

11.3.3.1.3.Y-o-Y Growth (%) 2024-2034F

11.3.3.2. Neurological Disorders

11.3.3.2.1.By Value (USD Million) 2024-2034F

11.3.3.2.2. Market Share (%) 2024-2034F

11.3.3.2.3. Y-o-Y Growth (%) 2024-2034F

11.3.3.3. Cardiovascular Diseases

11.3.3.3.1.By Value (USD Million) 2024-2034F

11.3.3.3.2. Market Share (%) 2024-2034F

11.3.3.3.3. Y-o-Y Growth (%) 2024-2034F

11.3.3.4. Inborn Errors of Metabolism

11.3.3.4.1.By Value (USD Million) 2024-2034F

11.3.3.4.2. Market Share (%) 2024-2034F

11.3.3.4.3. Y-o-Y Growth (%) 2024-2034F

11.3.3.5. Other

11.3.3.5.1.By Value (USD Million) 2024-2034F

11.3.3.5.2. Market Share (%) 2024-2034F

11.3.3.5.3. Y-o-Y Growth (%) 2024-2034F

11.3.4.By End User

11.3.4.1.Contract Research Organization

11.3.4.1.1. By Value (USD Million) 2024-2034F

11.3.4.1.2.Market Share (%) 2024-2034F

11.3.4.1.3.Y-o-Y Growth (%) 2024-2034F

11.3.4.2. Academic and Research Institutes

11.3.4.2.1.By Value (USD Million) 2024-2034F

11.3.4.2.2. Market Share (%) 2024-2034F

11.3.4.2.3. Y-o-Y Growth (%) 2024-2034F

11.3.4.3. Pharmaceutical and Biotechnology Companies

11.3.4.3.1.By Value (USD Million) 2024-2034F

11.3.4.3.2. Market Share (%) 2024-2034F

11.3.4.3.3. Y-o-Y Growth (%) 2024-2034F

11.3.4.4.Other End-users

11.3.4.4.1.By Value (USD Million) 2024-2034F

11.3.4.4.2. Market Share (%) 2024-2034F

11.3.4.4.3. Y-o-Y Growth (%) 2024-2034F

12.North America Metabolomics Market Size & Forecast 2024A-2034F

12.1.Overview 

12.2. Key Findings

12.3. Market Segmentation

12.3.1.By Product & Services

12.3.2. By Application

12.3.3. By Indication

12.3.4. By End User

12.4. Country

12.4.1.United States

12.4.2. Canada

13.Europe Metabolomics Market Size & Forecast 2024A-2034F

13.1.Overview 

13.2. Key Findings

13.3. Market Segmentation

13.3.1.By Product & Services

13.3.2. By Application

13.3.3. By Indication

13.3.4. By End User

13.4.Country

13.4.1.Germany

13.4.2. United Kingdom

13.4.3. France

13.4.4. Italy

13.4.5. Spain

13.4.6. Russia

13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)

14.Asia-Pacific Metabolomics Market Size & Forecast 2024A-2034F

14.1. Overview 

14.2. Key Findings

14.3.Market Segmentation

14.3.1.By Product & Services

14.3.2. By Application

14.3.3. By Indication

14.3.4. By End User

14.4. Country

14.4.1.India

14.4.2. China

14.4.3. South Korea

14.4.4.Japan

14.4.5.Rest of APAC

15.Middle East and Africa Metabolomics Market Size & Forecast 2024A-2034F

15.1.Overview 

15.2. Key Findings

15.3. Market Segmentation

15.3.1.By Product & Services

15.3.2. By Application

15.3.3. By Indication

15.3.4. By End User

15.4.Country 

15.4.1. Israel 

15.4.2. GCC

15.4.3. North Africa

15.4.4.South Africa

15.4.5. Rest of Middle East and Africa

16. Latin America Metabolomics Market Size & Forecast 2024A-2034F

16.1.Overview 

16.2. Key Findings

16.3. Market Segmentation

16.3.1.By Product & Services

16.3.2. By Application

16.3.3. By Indication

16.3.4. By End User

16.4.Country

16.4.1. Mexico

16.4.2. Brazil

16.4.3. Rest of Latin America

17. Competitive Landscape

17.1.Company market share, 2023

17.2. Key player overview

17.3. Key stakeholders

18. Company Profiles 

18.1.Agilent Technologies Inc.

18.1.1.Company Overview

18.1.2.Financial Overview

18.1.3.Key Product; Analysis

18.1.4.Company Assessment

18.1.4.1.Product Portfolio

18.1.4.2.Key Clients

18.1.4.3. Market Share 

18.1.4.4. Recent News & Development (Last 3 Yrs.)

18.1.4.5.Executive Team

18.2. Thermo Fisher Scientific Inc.

18.3. Waters Corporation

18.4. Bruker Corporation

18.5. Bio-Rad Laboratories, Inc.

18.6. PerkinElmer Inc.

18.7. Metabolon, Inc.

18.8. Human Metabolome Technologies Inc.

18.9. Shimadzu Corporation

18.10. LECO Corporation

18.11.Evotec SE

18.12. Asuragen Inc.

18.13. GeneBio

18.14. Danaher Corporation

18.15. Sciex (a Danaher Company)

18.16. Other Prominent Players

19. Appendix

20.Consultant Recommendation

Research Methodology

Primary Research

  • Fatpos Global’s dedicated primary research wing comprises a team of analysts adept at conducting and engaging in detailed primary interviews with key industry stakeholders across the entire value chain.
  • The primary research comprises formulation of a detailed discussion guides composed of questions pertaining to various data points essential developing an in-depth report.
  • The subsequent stages development of an exhaustive market participants, key opinion leaders, industry experts and executives, among others.
  • Manufacturers, distributors & suppliers, key End Users, industry experts, opinion leaders, and industry association members, among others compose the sample for the research study

Supply Side

  • R&D technicians and technologists
  • Procurement Managers
  • Physician If s/Specialist
  • Research Professors
  • Healthcare Providers
  • Consumers
  • Distributors & Channels
  • Service Provide

Demand Side

  • CEOs
  • Vice presidents
  • Marketing directors
  • RProduct Managers
  • Regional Sales and
  • Marketing Managers
  • Business Development
  • Plant Manage

Research Framework

    Objective of Research

  • The objective of the research is to provide a 360 holistic view on the market and bringing the insights that can help stakeholders identify the opportunities as well as challenges.
  • We have provided the market size in terms of value and volume of market with segmentation and offers in-depth commentary and accurate quantitative insights.
  • The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

    Primary Research

  • Fatpos Global’s dedicated primary research wing comprises a team of analyst adept at conducting and engaging in detailed primary interviews with key industry stakeholders across the entire value chain.
  • The primary research comprises formulation of a detailed discussion guides composed of questions pertaining to various data points essential developing an in-depth report.
  • The subsequent stages development of an exhaustive market participants, key opinion leaders, industry experts and executives, among others.
  • Manufacturers, distributors & suppliers, key End Users, industry experts, opinion leaders, and industry association members, among others compose the sample for the research study
  • Analysts compile the whole data from demand and supply-side perceptions

    Secondary Research

  • Data is gathered from various secondary databases.
  • Diligently tracking the secondary sources for closely monitoring the market trends and insights.
  • Analysts compile the whole data from demand and supply-side perceptions for the better outputs.

Data Sources

    Research Approach

  • Demand Estimation of each product across countries/regions summed from the total market
  • Variable analysis for demand forecasting
  • Demand estimation via analysing paid database, company financials either via annual report or database
  • Primary interviews for data revalidation and insights collection.
  • Used extensively for new product forecasting or analysing penetration level
  • Tool used invoices product flow & penetration models
  • Use of regression multi variate analysis for forecasting
  • Involve extensive use of paid and public database
  • Primary interviews & vendor-based primary research for variable impact analysis

Bottom-Up Approach

Top-Down Approach

To request a free sample copy of this report, please complete the form below.

Purchase Report

Select your license

$3199

Compare all license features

Note: In case you require a hard copy, there will be an additional charge of $500.

Sample request

Read all reports

Our Clients

We have been working with some Fortune 500+ clients